Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including "human on a chip" and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B.

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Vinod Rustgi has put together topics that provide a current clinical update on the treatment and management of patients with Hepatic Encephalopathy (HE). Experts in the field have contributetd clinical review articles on the following topics: Definition, Prevalence, and Epidemiology of HE; Pathophysiology of HE; Clinical Manifestations of HE; Laboratory Abnormalities of HE; Minimal or Subclinical HE; Prognosis of Prognosis of HE; Pharmacological Management of HE; Non-pharmacological Management of HE; Cost Burden of HE; Long-term management of HE: Modern Measures to Prevent Re-admission; Social Impact of HE; and Novel Therapies for HE. Readers will come away with the information they need to improve outcomes in patients with HE.